Utility of neuronal-derived exosomes to examine molecular mechanisms that affect motor function in patients with Parkinson disease
GLP-1 medications are not inherently lifelong treatments, but the duration of therapy varies considerably based on why you're taking them, your response to treatment, and your overall health goals
Sterile water is fine ifand only ifyou plan to use the entire contents of the vial in a single application immediately after reconstitution
Rebouche CJ, Engel AG
In addition to the US FDA approved GLP-1RAs, there are GLP1/glucagon dual agonists (Cotadutide, BI 456906), GIP/GLP1 dual agonists (Tirzepatide, GIP/GLP peptide I and II), GIP/GLP1/glucagon tri-agonists (HM15211, GGG tri-agonist) and GLP1R agonists (Efpeglenatide, Rybelsus) currently in phase 1- III clinical trials for T2D, obesity, and NASH (MASH) treatments (12)
2019;9(8):e027529